Cite
HARVARD Citation
Ignatiadis, M. et al. (2018). Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial. Annals of oncology. pp. 1777-1783. [Online].